Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT07139769

Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer

Led by Zeba Ahmad, Ph.D. · Updated on 2025-12-05

48

Participants Needed

1

Research Sites

44 weeks

Total Duration

On this page

Sponsors

Z

Zeba Ahmad, Ph.D.

Lead Sponsor

A

American Cancer Society, Inc.

Collaborating Sponsor

AI-Summary

What this Trial Is About

The study team aims to adapt a psychosocial intervention to reduce psychological distress among the caregiving parents of adolescents and young adults (aged 15-39) who have cancer. First, the study team will adapt an evidence-supported, group-based program for improving psychological resiliency (Stress Management and Resiliency Training - Relaxation Response Resiliency Program; SMART-3RP(E. R. Park et al., 2021)), and iteratively incorporate feedback from parents of AYA with cancer using a mixed-methods approach. Next, the study team will pilot the refined intervention to assess for preliminary indicators of feasibility, acceptability, and potential for efficacy in reducing parental distress.

CONDITIONS

Official Title

Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Self-identifying parent or guardian who provides primary informal caregiving to a child with cancer
  • Child or young adult receiving care is aged between 15 and 39 years and currently undergoing cancer treatment
  • Participant scores 2 or higher on the National Comprehensive Cancer Network Distress Thermometer (scale 0-10)
  • Participant is English-speaking
  • Participant is aged over 18 years
Not Eligible

You will not qualify if you...

  • Having a co-parent or other household member participating in the same study
  • Active symptoms of psychosis or suicidal thoughts that would make participation unsafe

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Mass General Brigham Cancer Institute at Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

Actively Recruiting

Loading map...

Research Team

Z

Zeba N Ahmad, Ph.D.

CONTACT

X

Xinghan Zhu, B.S.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here